Patent · US Active

Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor

US12098430B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 13, 2022
Grant dateSep 24, 2024
Priority date
Expiry dateDec 7, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This application provides a kit or a device for the detection of early pancreatic cancer or a pancreatic cancer precursor lesion, comprising a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting early pancreatic cancer or a pancreatic cancer precursor lesion, comprising measuring an expression level(s) of the miRNA(s) in vitro.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.